CLINICAL_TRIALS
trial_result
· 2022-03-14
Clinical Trial Update: Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS) [Phase 2]
Summary
Phase 2 dose-escalation trial of traditional Chinese medicine for irritable bowel syndrome has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED